Veterinary Medicines

CALCI–KEL 300, injekcinis tirpalas

Authorised
  • Calcium gluconate
  • Magnesium chloride
Download as PDF

Product identification

Medicine name:
CALCI–KEL 300, injekcinis tirpalas
Active substance:
  • Calcium gluconate
  • Magnesium chloride
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Calcium gluconate
    279.24
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
  • KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/97/0551/001
Date of authorisation status change:

Documents

RV0551.pdf

Lithuanian (PDF)
Published on: 23/08/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."